Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for those 65 and older

09/17/2021 | 04:29pm EDT

Sept 17 (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of illness, after rejecting a call for broader approval. (Reporting By Peter Henderson Editing by Bill Berkrot)


© Reuters 2021
All news about MODERNA, INC.
10/21MODERNA : U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccina..
BU
10/21MODERNA : U.S. administers over 411 mln doses of COVID-19 vaccines - CDC
RE
10/21MODERNA : U.S. CDC Says Delivered 498,702,405 Doses Of Covid-19 Vaccine As Of Oct 21
RE
10/21COVID VACCINE : CDC expands booster rollout, OKs mixing shots
AQ
10/21MODERNA : U.S. CDC signs off on Moderna, J&J COVID-19 vaccine boosters, mix-and-match shot..
RE
10/21MODERNA : U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match sh..
RE
10/21COVID-19 VACCINE : CDC panel backs expanded booster rollout
AQ
10/21Today on Wall Street: TRUTH will prevail
10/21MODERNA : CDC panel to vote on whether to authorize Moderna, J&J COVID-19 boosters
AQ
10/21MODERNA : EU regulator verdict on Moderna COVID-19 booster shot next week
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 335 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 11,4x
Yield 2021 -
Capitalization 137 B 137 B -
EV / Sales 2021 6,10x
EV / Sales 2022 5,37x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 339,57 $
Average target price 299,31 $
Spread / Average Target -11,9%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.225.04%137 066
LONZA GROUP AG29.18%59 339
IQVIA HOLDINGS INC.42.23%48 194
SEAGEN INC.-0.71%31 811
CELLTRION, INC.-39.42%25 446
ALNYLAM PHARMACEUTICALS, INC.57.21%24 224